CrushSCI.com
83Average days
81.5Median days
27Fastest days
154Longest days
842025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

86 days

Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid Arthritis After Tumor Necrosis Factor Inhibitor Use in the United States

Authors
Christina Charles-Schoeman; Kurt Oelke; Christopher D. Saffore; Aditi Kadakia; Yi Peng; Siran Fang; Greg Markley; Martin J. BergmanShow moreShow less
Affiliations
1. Division of Rheumatology, Department of Medicine, University of California, Los Angeles, USA; 2. Rheumatic Disease Center, Glendale, USA; 3. AbbVie Inc., North Chicago, USA; 4. Drexel University College of Medicine, Philadelphia, USAShow moreShow less
Source PDF DOI Publisher page
92 days

Sociodemographic and Clinical Determinants of Colchicine Adherence in Adults with Familial Mediterranean Fever: A Cross-Sectional Study

Authors
Ertugrul Cagri Bolek; Emre Bilgin; Riza Can Kardas; Levent Kilic; Sedat Kiraz; Ali Ihsan Ertenli; Alper Sari; Ali AkdoganShow moreShow less
Affiliations
1. Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye; 2. Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Türkiye; 3. Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya, Türkiye; 4. Department of Rheumatology, Ankara Etlik City Hospital, Ankara, TürkiyeShow moreShow less
Source PDF DOI Publisher page
142 days

Updates on the Evaluation of Lupus Arthritis

Authors
Wei Tang; Alberto Nordmann-Gomes; Leila Khalili; Giovanna Rosas; Ellen Montgomery; Laurel Zhang; Stephen Suh; Robert Clancy; Anca D. AskanaseShow moreShow less
Affiliations
1. Department of Medicine, Westchester Medical Center, Valhalla, USA; 2. Department of Medicine, Division of Rheumatology, Columbia University Irving Medical Center, New York, USAShow moreShow less
Source PDF DOI Publisher page
94 days

Real-World Steroid Burden, Treatment Patterns, and Rheumatologists’ Perceptions on Advanced Therapy in Giant Cell Arteritis

Authors
Anisha B. Dua; Aditi Kadakia; Patrick Zueger; Simran Marwaha; Nathaniel Zerad; Arathi Setty; William Jones; Valerie Devauchelle-PensecShow moreShow less
Affiliations
1. Northwestern University Feinberg School of Medicine, Chicago, USA; 2. AbbVie Inc., North Chicago, USA; 3. Adelphi Real World, Bollington, UK; 4. Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, FranceShow moreShow less
Source PDF DOI Publisher page
58 days

Fertility and Birth Outcomes in Rheumatoid Arthritis: A Narrative Review

Authors
Noel L. Ermer; Lisa R. Sammaritano; Caroline H. SiegelShow moreShow less
Affiliations
1. Division of Rheumatology, Hospital for Special Surgery, New York, USA; 2. Department of Medicine, Weill Cornell Medicine, New York, USAShow moreShow less
Source PDF DOI Publisher page
102 days

Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study

Authors
Caifeng Li; Junmei Zhang; Meiping Lu; Haiguo Yu; Li Sun; Qihua Feng; Zhihui Li; Jane Chen; Tiantian Liu; Junyi Wu; Xuan Zhou; Haomin QiuShow moreShow less
Affiliations
1. Department of Rheumatology, Beijing Children’s Hospital, Capital Medical University, Beijing, China; 2. Department of Rheumatology and Immunology, Children’s Hospital of Zhejiang University College of Medicine, Hangzhou, China; 3. Rheumatology and Immunology Department, Children’s Hospital of Nanjing Medical University, Nanjing, China; 4. Nephropathy Rheumatology Department, Children’s Hospital of Fudan University, Shanghai, China; 5. Rheumatology and Immunology Department, Children’s Hospital of Soochow University, Suzhou, China; 6. Nephropathy, Rheumatology and Immunology Department, Hunan Children’s Hospital, Changsha, China; 7. China R&D, GSK, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Rheumatology and Therapy take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for Rheumatology and Therapy. The fastest paper went from submission to acceptance in 27 days (Comparison of Systemic Corticosteroid Therapy Practices Between Pediatric and Adult Rheumatologists: A Multicenter Survey Study, received 2026-05-06, accepted 2026-06-02); the slowest took 154 days. The average is 83 days and the median is 81.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.